Novartis Names Drugs Chief as CEO to Deliver Return to Growth Novartis Names Drugs Chief as CEO to Deliver Return to Growth

Novartis CEO Joe Jimenez will step down on Feb. 1 and hand over to drug development chief Vas Narasimhan to decide the fate of $50 billion in assets and make good on a pledge to return the Swiss company to sales growth.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pharmacist News Source Type: news